Skip to Content
You are currently on the new version of our website. Access the old version .
  • Review
  • Open Access

22 January 2023

11 Pages

Biodrug Delivery Systems: Do mRNA Lipid Nanoparticles Come of Age?

,
,
and
Department of Pharmaceutical Sciences, University of Perugia, 06123 Perugia, Italy
*
Author to whom correspondence should be addressed.

Abstract

As an appealing alternative to treat and prevent diseases ranging from cancer to COVID-19, mRNA has demonstrated significant clinical effects. Nanotechnology facilitates the successful implementation of the systemic delivery of mRNA for safe human consumption. In this manuscript, we provide an overview of current mRNA therapeutic applications and discuss key biological barriers to delivery and recent advances in the development of nonviral systems. The relevant challenges that LNPs face in achieving cost-effective and widespread clinical implementation when delivering mRNA are likewise discussed.

Article Metrics

Citations

Article Access Statistics

Multiple requests from the same IP address are counted as one view.